CVS HEALTH Corp
CVS · CIK 0000064803 · Retail-Drug Stores and Proprietary Stores
About CVS HEALTH Corp
We serve an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (“PDP”).
Business information sourced from SEC annual filing filed Feb 10, 2026. Business descriptions reflect the cited filing and may not describe subsequent changes.
Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.
Financial highlights
Latest qualifying annual SEC observations · USDHistorical financial performance
USD billions · Annual SEC observations · Choose a metric
Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.
Annual financial history
USD · Exact fiscal period ends| Period ended | Revenue | Net income | Operating income | Assets | Liabilities | Cash | Operating cash flow | Net margin |
|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2025 | — | $1.77B | $4.66B | $253.54B | $178.16B | $8.45B | $10.64B | — |
| Dec. 31, 2024 | — | $4.61B | $8.52B | $253.22B | $177.48B | $8.59B | $9.11B | — |
| Dec. 31, 2023 | — | $8.34B | $13.74B | $249.73B | $173.09B | $8.20B | $13.43B | — |
| Dec. 31, 2022 | — | $4.31B | $7.95B | $228.28B | $156.51B | $12.94B | $16.18B | — |
| Dec. 31, 2021 | — | $8.00B | $13.31B | $233.00B | $157.62B | $9.41B | $18.26B | — |
| Dec. 31, 2020 | — | $7.18B | $13.91B | $230.72B | $161.01B | $7.85B | $15.86B | — |
| Dec. 31, 2019 | — | $6.63B | $11.99B | $222.45B | $158.28B | $5.68B | $12.85B | — |
| Jan. 1, 2019 | — | — | — | $216.67B | $157.95B | — | — | — |
A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.
Company information
- Registered name
- CVS HEALTH Corp
- Ticker symbol
- CVS
- CIK
- 0000064803
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC SIC code
- 5912
- Fiscal year end (MMDD)
- 1231
- Last SEC synchronization
- Nov 8, 2026 03:22 UTC
- Headquarters / business address
- ONE CVS DR.
WOONSOCKET, RI 02895 - Mailing address
- ONE CVS DR.
WOONSOCKET, RI 02895 - Business phone
- 4017651500
Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Last company information check: Nov 8, 2026 03:40 UTC. Official website, business descriptions and executive details require separate verification.
Latest SEC filings
Browse filings →| Form | Filed | Report period | Official source |
|---|---|---|---|
| 10-Q | Nov. 4, 2026 | Sept. 30, 2026 | View SEC filing ↗ |
| 10-Q | Aug. 5, 2026 | June 30, 2026 | View SEC filing ↗ |
| 10-Q | May 6, 2026 | March 31, 2026 | View SEC filing ↗ |
| 10-Q | Oct. 29, 2025 | Sept. 30, 2025 | View SEC filing ↗ |
| 10-Q | July 31, 2025 | June 30, 2025 | View SEC filing ↗ |
| 10-Q | May 1, 2025 | March 31, 2025 | View SEC filing ↗ |
| 10-Q | Nov. 6, 2024 | Sept. 30, 2024 | View SEC filing ↗ |
| 10-Q | Aug. 7, 2024 | June 30, 2024 | View SEC filing ↗ |
| 10-Q | May 1, 2024 | March 31, 2024 | View SEC filing ↗ |
| 10-Q | Nov. 1, 2023 | Sept. 30, 2023 | View SEC filing ↗ |
| 10-Q | Aug. 2, 2023 | June 30, 2023 | View SEC filing ↗ |
| 10-Q | May 3, 2023 | March 31, 2023 | View SEC filing ↗ |
| 10-Q | Nov. 2, 2022 | Sept. 30, 2022 | View SEC filing ↗ |
| 10-Q | Aug. 3, 2022 | June 30, 2022 | View SEC filing ↗ |
| 10-Q | May 4, 2022 | March 31, 2022 | View SEC filing ↗ |
| 10-Q | Nov. 3, 2021 | Sept. 30, 2021 | View SEC filing ↗ |
| 10-Q | Aug. 4, 2021 | June 30, 2021 | View SEC filing ↗ |
| 10-Q | May 4, 2021 | March 31, 2021 | View SEC filing ↗ |
| 10-Q | Nov. 6, 2020 | Sept. 30, 2020 | View SEC filing ↗ |
| 10-Q | Aug. 5, 2020 | June 30, 2020 | View SEC filing ↗ |
Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.